Objective. To determine risk factors for primary Sj€ ogren's syndrome (SS)-associated lymphoma in a multicenter cohort of patients, with analysis of the predictive power of previously reported risk factors, including the presence of ectopic germinal center (GC)-like structures in minor salivary gland (MSG) biopsy tissue.
Objective. To determine risk factors for primary Sj€ ogren's syndrome (SS)-associated lymphoma in a multicenter cohort of patients, with analysis of the predictive power of previously reported risk factors, including the presence of ectopic germinal center (GC)-like structures in minor salivary gland (MSG) biopsy tissue.
Methods. One hundred fifteen patients with primary SS were included, and MSG biopsy tissue from these patients was retrospectively examined, focusing on the presence of ectopic GC-like structures. Epidemiologic, clinical, biologic, immunologic, and histologic data were collected at the time of diagnosis of primary SS. Patients with non-Hodgkin's lymphoma (NHL) were compared with those without NHL during the follow-up period, using a Cox proportional hazards multiple regression model.
Results. NHL was diagnosed in 8 patients (6.96%), and ectopic GC-like structures in 19 patients (16.5%). The presence of ectopic GC-like structures was associated with a 7.8-fold increased risk of lymphoma occurrence (95% confidence Conclusion. The presence of ectopic GC-like structures in MSG biopsy tissue is associated with the risk of lymphoma in patients with primary SS. These data reinforce the major role of MSG biopsy tissue in primary SS, for the identification a priori of a subgroup of patients with the highest risk of lymphoma.
Primary Sj€ ogren's syndrome (SS) is known to be associated with a 6-20-fold increased risk of lymphoma compared with the risk in the general population and is the one that is associated with the highest risk among all of the other connective tissue diseases and inflammatory arthritis (1) (2) (3) . Lymphoma is also considered to be the main risk factor for death in patients with primary SS (4, 5) .
As recently reported (6) , the main predictors of or risk factors for lymphoma occurrence in patients with primary SS include purpura (2, 7, 8) , parotid gland enlargement (7, (9) (10) (11) (12) , splenomegaly (13) , lymphadenopathy (7, 10, 13) , peripheral neuropathy (11, 14) , leukopenia (12) , neutropenia (13) , lymphopenia (2, 15, 16) , CD4 T cell lymphopenia (2, 15) , cryoglobulinemia (8, 12, 13, 17) , low serum level of C4 (2, 7, 8, (11) (12) (13) 16) , low serum level of C3 (2, 16, 18) , and the presence of anti-SSA/Ro (7) or anti-SSB/La antibodies (7, 12) . More recently, a lack of anti-SSA/SSB antibodies was considered to be protective against lymphoma development (19) . Finally, the European League Against Rheumatism SS Disease Activity Index (ESSDAI) score (20) was shown in one study to be associated with the risk of lymphoma onset (21) .
In 2011, Theander et al obtained innovative data by analyzing the association between ectopic germinal center (GC)-like structures in minor salivary gland (MSG) biopsy tissue. Those investigators concluded that such structures in MSG biopsy tissue were associated with a higher risk of lymphoma, and inversely, tissue without ectopic GC-like structures was associated with a lower risk (15) . The intensity of MSG biopsy tissue inflammatory infiltrates, as estimated by the focus score, has also been shown to be associated with a higher risk of lymphoma (22) .
Ectopic GC-like structures are associated with anti-Ro/SSA and anti-La/SSB antibodies, hypergammaglobulinemia, salivary gland swelling, a higher focus score, extraglandular manifestations, and a higher level of proinflammatory cytokines (23) (24) (25) . Many of these parameters are being considered as predictors of lymphoma occurrence.
Considering the high significance of and interest in ectopic GC-like structures as being able to easily predict the risk of lymphoma in primary SS (15), we sought to investigate this issue in a multicenter cohort of patients, with analysis of the prediction power (hazard ratio [HR] ) at any time during the follow-up of all previously reported risk factors, including the presence of ectopic GC-like structures in MSG biopsy tissue.
PATIENTS AND METHODS
Study design. All included patients were followed up at 3 French university hospitals (Piti e-Salpêtri ere, Lariboisi ere, and Bichat) and fulfilled the 2002 AmericanEuropean Consensus Group (AECG) criteria for primary SS (26) . The study was designed to include only primary SS patients for whom an MSG biopsy specimen was available for further analysis. Thus, 115 patients were included in the current study, and their MSG biopsy specimens were examined, with special attention to the focus score and the presence of ectopic GC-like structures.
The duration of follow-up was defined as the time interval between the diagnosis of primary SS and the date of the diagnosis of lymphoma or the date at which the last information was available for patients without lymphoma. For each patient, all medical records obtained during the follow-up period were retrospectively reviewed. Epidemiologic (age at diagnosis of primary SS, sex, ethnic origin), clinical, biologic, immunologic, and histologic data were obtained from medical records.
Glandular manifestations included xerostomia, xerophthalmia, and parotid gland enlargement or parotiditis. Extraglandular manifestations included pulmonary involvement, arthralgia, sensory or sensorimotor neuropathy, kidney involvement, purpura, splenomegaly (as determined by ultrasonography or computed tomography scanning), lymph node enlargement, and non-Hodgkin's lymphoma (NHL). Peripheral sensory and sensorimotor neuropathies were defined by suggestive clinical and electric nerve conduction study abnormalities (27) .
Biologic parameters included complete blood cell count, serum gamma globulin level, serum level of C4, cryoglobulin positivity, rheumatoid factor (RF) activity, monoclonal gammopathy, antinuclear antibodies (ANAs), anti-SSA antibodies, and anti-SSB antibodies. ESSDAI or clinESSDAI scores (20, 28) were not recorded.
Definition and identification of ectopic GCs in MSG biopsy tissue. Pathologic analyses were performed by CF and KR. Tissue sections were fixed in 10% formalin solution, and paraffin sections were stained with hematoxylin and eosin (H&E). For each specimen, 3 sections (3 lm thick) on different levels in the paraffin block were examined. The glandular area was measured with a calibrated eyepiece grid for calculation of the focus score. Ectopic GC-like structures were defined by the presence of a well-circumscribed aggregate of lymphoid cells consisting of at least 50 cells presenting with features of centroblasts admixed with a few centrocytes and associated with follicular dendritic cells within otherwise normal salivary gland epithelium ( Figure 1A) , with low expression of Bcl-2 and high Bcl-6 reactivity ( Figures 1B and C) . Statistical analysis. For MSG biopsy analysis and focus score assessment, the reliability of the readers (CF and KR) was assessed by the percent absolute agreement, the kappa value for interrater agreement, and the intraclass correlation coefficient. To determine predictors of or risk factors for lymphoma occurrence, patients presenting with NHL were compared with those without NHL during the follow-up period, using a Cox proportional hazards multiple regression model, with results expressed as the HR. We first performed univariate analysis for each variable and, on the basis of these results, selected variables (P < 0.20 on univariate analysis) were included in multivariate analyses using a stepwise multiple regression analysis to assess independent risk factors. To verify the reliability and the robustness of the NHL predictors identified by the Cox proportional hazards multiple regression model, a Cox regression for clinical model (200 samples) was performed using the bootstrap method. All P values were 2-tailed, and P values less than 0.05 were considered significant. All analyses were performed using MedCalc software version 10.0.1.0, except for the bootstrap Cox regression, which was performed using SAS 9.4 software (SAS Institute).
RESULTS
Study population. The main characteristics of the 115 included patients are shown in Table 1 . All of the participants fulfilled the AECG criteria (26) . The median age at the time of primary SS diagnosis was 53.7 years (95% confidence interval [95% CI] 50-56 years). The median follow-up duration or time to NHL occurrence was 51 months (95% CI 42-66.5 months). Thirteen percent of the patients were male, 53.9% were of European descent (Caucasian), 22.6% were of Arabic descent (Maghrebi), and 20% were of African descent. NHL was diagnosed in 8 patients (6.96%) (95% CI 2.2-11.7%) and included 1 diffuse large B cell lymphoma, 5 mucosaassociated lymphoid tissue (MALT) lymphomas (parotid
, and 2 medullar and marginal-zone lymph node lymphomas.
Glandular manifestations included xerostomia (89.6% of patients), xerophthalmia (97.4% of patients), and parotiditis or parotid gland enlargement (9.6% of patients). Extraglandular manifestations were mainly arthralgia (62.6% of patients) and peripheral neuropathies (19% of patients) but included 5 cases of sensorimotor neuropathy (4.3% of patients) and 5 cases of splenomegaly (4.3% of patients).
Histologic data showed a positive result for MSG biopsy (focal lymphocytic sialadenitis with a focus score of ≥1 focus/4 mm 2 ) in 76.5% of patients, and ectopic GC-like structures were observed in 16.5% (19 patients Table 3 ). The bootstrap Cox regression for clinical model (200 samples) confirmed the reliability of the 2 identified independent variables, providing evidence that the presence of ectopic GC-like structures in MSG biopsy tissue and cryoglobulin remained the best predictors with higher good predictor bootstrap samples percentage (58.0% and 50.50%, respectively) ( Table 4) . * The analysis was performed using a Cox proportional hazards multiple regression model. Except where indicated otherwise, values are the number (%). For male sex, P = 0.0005; for African ancestry, P = 0.029; for parotid gland enlargement, P = 0.045; for splenomegaly and sensorimotor neuropathy, P = 0.0001; for ectopic germinal centers, P = 0.084; for low C4 level, P = 0.048; for serum cryoglobulin, P = 0.009, patients with non-Hodgkin's lymphoma (NHL) versus patients without NHL. All other P values were not significant. HR = hazard ratio; 95% CI = 95% confidence interval; IQR = interquartile range; IgM-RF = IgM rheumatoid factor. * NHL = non-Hodgkin's lymphoma; HR = hazard ratio; 95% CI = 95% confidence interval; GCs = germinal centers; MSG = minor salivary gland. Figure 2 ). Because the finding that male sex was a predictor of lymphoma in primary SS was unusual, we built a new multivariate model (model 2) excluding male sex, after which only splenomegaly remained an independent clinical risk factor (HR 19.9, 95% CI 4.4-90 [P = 0.0001]). The bootstrap resampling procedure (200 samples) confirmed the stability of our Cox multiple regression model, providing evidence that male sex (51.5%) and sensorimotor neuropathy (47.50%) remained the best NHL predictors (Table 4) .
Multivariate analysis of clinical, histologic, and biologic risk factors for developing lymphoma in primary SS. Finally, we built a global model including all significant clinical, biologic, and histologic variables and performed a new Cox multiple regression analysis. Two variables remained independently significant predictors of lymphoma occurrence: ectopic GC-like structures (HR 7.8, 95% CI 1.5-57 [P = 0.016]) and male sex (HR 12, 95% CI 2.5-57 [P = 0.002]).
DISCUSSION
Our study provided evidence that ectopic GC-like structures in MSG biopsy tissue represent an independent risk factor for the occurrence of lymphoma in patients with primary SS, with a 7.8-fold increased risk. We also confirmed cryoglobulin (HR 7.10), and also identified male sex (HR 28.73) and sensorimotor neuropathy (HR 35.48) as other new significant independent risk factors for lymphoma development in patients with primary SS.
The mean AE SD prevalence of ectopic GC-like structures among patients with primary SS is estimated to be 25 AE 5% (23). Our results confirmed that the ectopic GC-like structures in the MSG might be a predictor of NHL in patients with primary SS, as reported by Theander et al in 2011 (15) . In their benchmark study, Theander et al observed that 7 (4%) of the 175 included patients developed a lymphoma after an average followup of 10.6 years, with a higher prevalence among patients with ectopic GC-like structures in MSG biopsy tissue (14%) than that among patients without these structures (0.8%) (15) . Moreover, other investigators reported that up to 75-86% of primary SS-associated lymphomas are associated with ectopic GC-like structures in MSG biopsy tissue (15, 29) . Of note, other investigators failed to demonstrate such an association. Carubbi et al were unable to provide evidence of an independent association between ectopic GC-like structures and lymphoma (24) . However, that study revealed 2 major differences compared with the current study and others: a higher prevalence of ectopic GC-like structures (56% of 104 patients) and a lower prevalence of lymphoma, because only 2 patients (2%) had lymphoma (all had ectopic GC-like structures).
More recently, Haacke et al observed ectopic GC-like structures in 2 of 11 (18%) H&E-stained sections and 3 of 11 (27%) Bcl-6-stained sections. In controls, GCs were present in 4 of 22 (18%) H&E-stained sections and 5 of 22 (23%) Bcl-6-stained sections (30) . However, their study population did not represent the diversity of patients with primary SS, because only anti-SSA-positive patients and patients with parotid gland MALT lymphoma were included, thus rendering the comparison with other studies inappropriate. Finally, Johnsen et al also failed to demonstrate an association between ectopic GC-like structures and lymphoma when comparing the prevalence of ectopic GC-like structures and B cell clonality in primary SS patients with lymphoma (n = 12) and those without lymphoma (n = 28) (31). However, and of importance, their study was not statistically designed to evaluate the relative risk of lymphoma occurrence produced by the presence of ectopic GC-like structures. Moreover, they included a smaller number of patients (resulting in weak statistical power) and used a different method for detection of ectopic GC-like structures (i.e., H&E staining and double staining for CD21/IgD and CD38/IgD); this resulted in a high prevalence of ectopic GC-like structures in both groups (33% versus 46%).
The higher sensitivity of CD21 immunohistochemical staining for the detection of ectopic GC-like structures was recently confirmed by Lee et al, with GC formation observed in 30% of patients (32) . These discrepancies led us to question the best definition of ectopic GC-like structures in MSG biopsy tissue and to call for consensus guidelines to standardize assessment of ectopic GC-like structures in MSG biopsy tissue and other histologic parameters (proliferation and functional markers [Ki-67 and activation-induced deaminase (AID)]) (33) . However, many of these parameters (e.g., CD21L and AID) are not technically suitable for easy automated detection in routine diagnostics or might overestimate (CD21L) or underestimate (AID) the prevalence of ectopic GC-like structures in MSG biopsy tissue (34) . Thus, the question remained unsolvable, and consensus guidelines for pathologists are needed for standardization of the correct evaluation of ectopic GC-like structures in MSG tissue.
The mechanisms underlying the association between ectopic GC-like structures and lymphoma are not yet well defined (35) . Bombardieri et al demonstrated that in the SGs of patients with primary SS, AID (the enzyme responsible for class-switch recombination and somatic hypermutation) is associated with ectopic GC-like structures in primary SS-associated MALT lymphoma (29) . Moreover, the presence of ectopic GC-like structures in MSG biopsy tissue is frequently associated with long-term activation of autoreactive B cells (25) and an immunologically active disease with the production of autoantibodies (ANAs, anti-SSA, and anti-SSB), high RF titer, and hypergammaglobulinemia (15, 23, 24, 36) . Finally, ectopic GC-like structures are associated with higher levels of numerous chemokines, including CXCL-13 and CCL-11 (23) (24) (25) , the levels of which were significantly higher in patients with primary SS-associated NHL (37) . Thus, there is a significant corpus of clinical and immunologic evidence favoring the predictive power of the presence of ectopic GC-like structures in MSG biopsy tissue in patients with primary SS-associated lymphoma.
S ENE ET AL
We have also confirmed cryoglobulin as being a significant predictor of primary SS-associated lymphoma leading to a 7.10-fold risk of lymphoma. This result is consistent with those of previous studies (8, 12, 13, 17) , with serum cryoglobulin being the more consensual identified risk factor for lymphoma occurrence in primary SS. In univariate analysis, a low C4 serum level was also demonstrated to be associated with a higher risk of lymphoma occurrence, as previously reported (2, 7, 8, (11) (12) (13) 16, 21) . The same is true for RF and monoclonal gammopathy, which were more frequently observed in patients with lymphoma, are usually predictive of cryoglobulinemia, and have been identified as possible predictors of the development of lymphoma (21) .
With regard to clinical predictors of lymphoma, parotid gland enlargement (7, (9) (10) (11) (12) , sensorimotor neuropathy (11, 14) , and splenomegaly (13, 21) , which are considered to be significant markers of primary SS disease activity, were confirmed as drivers of the excessive risk of lymphoma occurrence. However, the low number of cases of splenomegaly (5) or sensorimotor neuropathy (5) suggests that these results should be considered with caution. Surprisingly, we did not identify purpura as an independent predictor; however, the prevalence of purpura was twice as high in patients with lymphoma as in those without lymphoma, and several previous studies have shown an association of purpura with primary SS-associated lymphoma (2, 7, 8, 21) .
Unexpectedly, we identified male sex as a clinical predictor of primary SS-associated lymphoma. Indeed, male sex was shown to drive a dramatic 12-28.7-fold HR of lymphoma development. The explanation for the association between male sex and lymphoma occurrence is not clearly explained, because none of the previous studies has shown evidence of a sex-related higher risk of lymphoma in patients with primary SS (38) . Moreover, the excess risk of lymphoma has been shown to be driven by female sex, mainly for marginal-zone lymphoma in connective tissue diseases (39) . Therefore, this result should be interpreted with caution, taking into account the small number of patients with lymphoma in our study, even if more severe and active disease in male patients cannot be ruled out.
Our study has some critical pitfalls. The first is its retrospective design, which might lead to missing data and selection bias. However, this limitation has not altered the intrinsic quality of our population study features, which were quite comparable with those of previous studies. The second limitation is the small number of patients with lymphoma (8 of 115 patients), leading to caution with the statistical analyses. For these reasons, we decided to perform an additional statistical analysis using a bootstrap Cox regression for clinical model, the results of which finally confirmed the reliability and robustness of the NHL predictors identified by the Cox model (see Table 4 ). In addition, our results are largely consistent with those of previous studies. Another criticism might be the lack of recording of scores for primary SS activity, because this retrospective study did not include the ESSDAI score, which was recently described (20) , was shown to be linked to higher risk of death in primary SS with high disease score activity (40) , and was recently identified as a possible predictor of lymphoma in primary SS (21) .
In summary, our results have confirmed that the presence of ectopic GC-like structures in MSG biopsy tissue is significantly associated with a high risk of primary SS-associated lymphoma, along with the consensual clinical (parotid enlargement, sensorimotor neuropathy, splenomegaly) and biologic (serum cryoglobulin, low C4 serum level) predictors, and, unexpectedly, male sex. These data reinforce the major role of MSG biopsy tissue in primary SS management for the diagnosis of primary SS and for a better definition of the subgroup of patients with the highest risk of lymphoma development.
